Connect with us

CBD News

“Father Of Cannabis Research” To Be Honored With First Lifetime Achievement Award And $10,000 Grant

Published

on

The-Father-of-Cannabis-Research-Raphael-Mechoulam-to-be-Honored-with-First-Lifetime-Achievement-Award-and-10000-Research-Grant

The Father of Cannabis Research”, Raphael Mechoulam, is being honored by The Arcview Group with a Lifetime Achievement Award. There will also be a $10,000 research grant in their first annual cannabis awards presentation at the Arcview Investor Forum: The Evolution of Cannabis 2020. This awards presentation will take place in New York on Thursday, October 3, 2019. Mechoulam’s contribution to the understanding and utilization of cannabis for positive benefits is unmatched. He is being recognized for his cutting-edge cannabis research and breakthrough discovery of THC.

Arcview will be preserving and continuing the invaluable work of Mechoulam by naming future recipients of this award the “Arcview Raphael Mechoulam Lifetime Acheivement Award”.

The Arcview Group CEO and co-founder, Troy Dayton, stated that “Cannabis research has never been more critical to the future of our industry, especially as the federal government begins processing dozens of pending applications for the steps necessary to improve access to marijuana research”.

As Raphael is the first person to synthesize THC, identify the endocannabinoid system, and illustrate the medicinal properties of cannabis, no one is more deserving for the award.

The Arcview Investor Forum will bring together the biggest fund managers, CEOs of the largest cannabis companies, and key investors in the industry. Arcview’s members have also selected seven cannabis companies that will present to investors in a ‘Shark Tank’ style format. Space to attend the forum is extremely limited, at this time. Accredited investors interested in attending the forum. A special “Preview Day” will launch for the first time ever on Wednesday, October 2, 2019. If you wish to be a part of this event, you can register at http://events.arcviewgroup.com/.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.